المؤلفون: Kapp-Schwoerer S; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Weber D; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Corbacioglu A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Gaidzik VI; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Paschka P; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Krönke J; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Theis F; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Rücker FG; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Teleanu MV; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Panina E; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Jahn N; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Herzig J; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Kubanek L; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Schrade A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Göhring G; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Fiedler W; Hubertus Wald University Cancer Center, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Kindler T; Department of Hematology, Medical Oncology, and Pneumology, University Cancer Center Mainz, Mainz, Germany., Schroeder T; Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Mayer KT; Department of Hematology and Oncology, University Hospital Bonn, Bonn, Germany., Lübbert M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Wattad M; Department of Hematology, Oncology and Stem Cell Transplantation, Kliniken Essen Süd, Essen, Germany., Götze KS; III. Department of Medicine, Hematology, and Medical Oncology, Technical University of Munich, Munich, Germany., Horst HA; Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany., Koller E; III. Department of Medicine, Hematology, and Medical Oncology, Hanuschkrankenhaus Wien, Vienna, Austria., Wulf G; Department of Hematology and Oncology, Georg-August-University Göttingen, Göttingen, Germany., Schleicher J; Department of Hematology and Oncology, Katharinenhospital Stuttgart, Stuttgart, Germany., Bentz M; Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany., Krauter J; Department of Internal Medicine III, Municipal Hospital of Braunschweig, Braunschweig, Germany., Bullinger L; Department of Hematology, Oncology, and Tumorimmunology, Charité University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany., Krzykalla J; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Schlenk RF; Nationales Centrum für Tumorerkrankungen Trial Center, National Center of Tumor Diseases, German Cancer Research Center, Heidelberg, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany; and., Thol F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.

المصدر: Blood [Blood] 2020 Dec 24; Vol. 136 (26), pp. 3041-3050.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/mortality , Mutation*, Gemtuzumab/*administration & dosage , Neoplasm Proteins/*genetics , Nuclear Proteins/*genetics, Adult ; Aged ; Aged, 80 and over ; Bone Marrow ; Disease-Free Survival ; Female ; Gemtuzumab/adverse effects ; Humans ; Male ; Middle Aged ; Neoplasm, Residual ; Nucleophosmin ; Prospective Studies ; Recurrence ; Risk Factors ; Survival Rate

المؤلفون: Held SA; Medizinische Klinik III, Hämatologie/Onkologie; Wilhelmstr. 35-37, 53111 Bonn in Sigmund-Freud- Str. 25, 53105 Bonn, Germany. Peter.Brossart@ukb.uni-bonn.de., Heine A, Mayer KT, Kapelle M, Wolf DG, Brossart P

المصدر: Current cancer drug targets [Curr Cancer Drug Targets] 2013 Sep; Vol. 13 (7), pp. 768-74.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101094211 Publication Model: Print Cited Medium: Internet ISSN: 1873-5576 (Electronic) Linking ISSN: 15680096 NLM ISO Abbreviation: Curr Cancer Drug Targets Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy/*trends , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*therapy, Animals ; Antibodies, Monoclonal/therapeutic use ; Antigens, Neoplasm/genetics ; Antigens, Neoplasm/immunology ; Dendritic Cells/immunology ; Dendritic Cells/transplantation ; Genetic Therapy/trends ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/immunology ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology ; Treatment Outcome